& Mushtaq, U
PubMed 35658024 ] MounjarotirzepatideNEJMDiabetes Care tirzepatideTGLDL-CHDL-CDiabetes Care TG 20%Diabetes Care, 2022[1] GLP-1 GIP SURPASS tirzepatide HbA1c 1.5%2.6%NEJM, 2021[2] tirzepatide SURMOUNT-1 72 15%21% 40% 20%NEJM, 2022[3] GLP-1 NAFLDtirzepatideHepatologytirzepatideFFA ALT Hepatology, 2023[4] MounjaroWegovy GLP-1 GIP GLP-1 MEN2 MounjaroWegovySaxendaOzempicVictozaTrulicity ( ) NT$10,000$24,000 NT$2,500$6,000 2.5mg5mg 2.5mg 5mg 2.5mg NT$10,000$13,000 5mg NT$13,000$18,000 5 10mg15mg 2.5mg 5mg NEJM SURMOUNT-1 tirzepatide 8 12 5% 72 1 15 mg/ 20.9% GLP-1 semaglutide 14% Jastreboff et al., 2022, NEJM[1] SURPASS 10 mg 40 8.8 HbA1c Rosenstock et al., 2021, NEJM[2] 23 6 812 5% 72 1.5 20.9% NEJM, 2022 40 8.8 NEJM, 2021 1 2/3 Rubino et al., 2021, JAMA[3] GLP-1 1 2/3 JAMA, 2021 GLP-1/GIP 15mg 5mg Jastreboff AM, et al
The truth is that SIBO is an overgrowth of bacteria you dont necessarily want a lot of not that its pathogenic necessarily, but its also not beneficial
No, you should never inject medication into skin that is currently red, bruised, infected, or has an active rash or open wound
